Genovis AB (publ.) (STO:GENO)
20.05
+1.03 (5.42%)
Jul 24, 2026, 5:29 PM CET
Genovis AB (publ.) Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 157.19 | 163.19 | 169.44 | 123.26 | 72.83 | 81.31 |
Cash & Short-Term Investments | 157.19 | 163.19 | 169.44 | 123.26 | 72.83 | 81.31 |
Cash Growth | -6.98% | -3.69% | 37.47% | 69.25% | -10.44% | 84.31% |
Accounts Receivable | - | 24.78 | 17.43 | 15.24 | 16.91 | 12 |
Other Receivables | - | 1.96 | 2.93 | 1.65 | 1.67 | 0.78 |
Total Trade Receivables | - | 26.74 | 20.35 | 16.89 | 18.58 | 12.78 |
Inventory | - | 11.89 | 13.44 | 14.91 | 12.56 | 12.42 |
Other Current Assets | 46.62 | 4.8 | 4.96 | 3.98 | 3 | 2.34 |
Total Current Assets | 203.81 | 206.62 | 208.19 | 159.04 | 106.97 | 108.85 |
Net Property, Plant & Equipment | 80.91 | 83.93 | 89.16 | 95.26 | 15.81 | 9.6 |
Other Intangible Assets | 132.68 | 45.82 | 8.26 | 12.82 | 12.72 | 12.36 |
Goodwill | - | 33.49 | 0 | 4.57 | 4.75 | 4.12 |
Long-Term Investments | 0.13 | 0 | 22.35 | 0 | 0 | 0 |
Other Long-Term Assets | 10.31 | 8.08 | 10.58 | 17.17 | 10.26 | 6.82 |
Total Assets | 427.84 | 377.93 | 327.41 | 288.86 | 150.52 | 141.75 |
Accounts Payable | - | 3.76 | 3.37 | 4.3 | 5.45 | 2.54 |
Accrued Expenses | - | 14.48 | 11.49 | 10.84 | 7.98 | 18.72 |
Current Portion of Leases | - | 6.33 | 5.36 | 4.51 | 2.89 | 1.71 |
Other Current Liabilities | - | 3.51 | 7.97 | 1.57 | 1.69 | 1.28 |
Total Current Liabilities | 35.41 | 28.07 | 28.2 | 21.23 | 18.01 | 24.25 |
Long-Term Leases | - | 66.76 | 71.25 | 74.81 | 4.44 | 1.12 |
Other Long-Term Liabilities | 11.28 | 11.58 | 0 | 2.01 | 2.43 | 2.39 |
Total Long-Term Liabilities | 73.15 | 78.34 | 71.25 | 76.82 | 6.86 | 3.51 |
Total Liabilities | 108.56 | 106.41 | 99.44 | 98.05 | 24.87 | 27.76 |
Common Stock | - | 16.52 | 16.37 | 16.37 | 16.37 | 16.37 |
Additional Paid-in Capital | - | 231.35 | 215.66 | 215.66 | 215.66 | 215.65 |
Accumulated Other Comprehensive Income | - | 11.09 | 6.88 | 2.64 | -1.02 | -2.45 |
Retained Earnings | - | 12.57 | -10.93 | -43.85 | -105.35 | -115.58 |
Shareholders' Equity | 308 | 271.52 | 227.97 | 190.81 | 125.65 | 113.99 |
Total Liabilities & Equity | 427.84 | 377.93 | 327.41 | 288.86 | 150.52 | 141.75 |
Total Debt | - | 73.08 | 76.6 | 79.32 | 7.32 | 2.83 |
Net Cash (Debt) | 157.19 | 90.11 | 92.84 | 43.94 | 65.51 | 78.48 |
Net Cash Growth | 74.44% | -2.94% | 111.29% | -32.92% | -16.53% | 109.53% |
Net Cash Per Share | 2.38 | 1.37 | 1.42 | 0.67 | 1.00 | 1.20 |
Book Value | 308 | 271.52 | 227.97 | 190.81 | 125.65 | 113.99 |
Book Value Per Share | 4.65 | 4.13 | 3.48 | 2.91 | 1.92 | 1.74 |
Tangible Book Value | 175.32 | 192.22 | 219.71 | 173.42 | 108.18 | 97.52 |
Tangible Book Value Per Share | 2.65 | 2.92 | 3.36 | 2.65 | 1.65 | 1.49 |